Combined company joins two leading brands in cancer diagnostics, Cologuard® and Oncotype DX®, providing a strong platform for continued growth   MADISON, Wis., November 8, 2019 – Exact Sciences Corp....

Data to be Presented at AASLD 2019, Abstract Selected for The Best of the Liver Meeting® BOSTON – November 8, 2019 (NASDAQ: EXAS) – A new study of 443 patients by Exact Sciences Corp. and its...

Researchers Shared Findings on Novel Markers at the American College of Gastroenterology’s 2019 Annual Scientific Meeting in San Antonio Data from BLUE-C Prospective Study is Expected to Support FDA...